Blogs and Insights on Neuroscience Research
The POWER1 Study: Exploring Innovative Solutions for Focal Onset Seizures
The POWER1 Study: Advancing Epilepsy Research with Flexible, Home-Based Participation Focus Keyword: focal onset seizures clinical trial What is the POWER1 Study?The POWER1 Study evaluates a new investigational medication, vormatrigine, for adults with focal onset seizures. Participants can contribute to cutting-edge epilepsy research while potentially gaining access to a promising treatment. Why Join the POWER1…
Explore the SOSTOS Clinical Trial: Advancing MS Treatments in Arizona
Are you living with relapsing-remitting multiple sclerosis (RRMS) and stable on treatment for the past 6 months? The SOSTOS Study is now enrolling participants in Arizona and nearby states to explore whether switching treatments can better protect against underlying nervous system damage in MS patients. Join us at Arizona Neuroscience Research and contribute to cutting-edge…
Join the VISTA Clinical Trial: Advancing MS Treatment Options in Arizona
Are you living with relapsing-remitting multiple sclerosis (RRMS) in Arizona or nearby states? The VISTA Study is now enrolling participants to evaluate an innovative oral therapy, PIPE-307, that may provide new hope for individuals managing RRMS. Conducted in collaboration with Arizona Neuroscience Research, this clinical trial represents a critical step in the fight against MS.…
Advancing MS Treatment: Participate in the REMODEL-2 Clinical Trial in Arizona
Are you living with relapsing multiple sclerosis (RMS) in Arizona or nearby states? Here’s your chance to contribute to a groundbreaking clinical trial that could revolutionize MS treatment. The REMODEL-2 (CLOU064C12302) study, sponsored by Novartis, is now enrolling participants in Arizona and surrounding regions. About the REMODEL-2 Study The REMODEL-2 clinical trial is a Phase…
